Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia

Mol Cell Neurosci. 2005 Dec;30(4):523-37. doi: 10.1016/j.mcn.2005.08.016. Epub 2005 Oct 3.

Abstract

Activation of intracellular signaling pathways involving p38 and p42/44 MAP kinases may contribute importantly to synaptic plasticity underlying spinal neuronal sensitization. Inhibitors of p38 or p42/44 pathways moderately attenuated responses of dorsal horn neurons evoked by mustard oil but not brush and alleviated the behavioral reflex sensitization seen following nerve injury. Activation of p38 and p42/44 MAP kinases in spinal cord ipsilateral to constriction injury was reduced by antagonists of NMDA, VPAC2 and NK2 (but not related) receptors, the glial inhibitor propentofylline and inhibitors of TNF-alpha. A VPAC2 receptor agonist enhanced p38 phosphorylation and caused behavioral reflex sensitization in naïve animals that could be blocked by co-administration of p38 inhibitor. Conversely, an NK2 receptor agonist activated p42/44 and caused behavioral sensitization that could be prevented by co-administration of p42/44 inhibitor. Thus, spinal p38 and p42/44 MAP kinases are activated in neuropathic pain states by mechanisms involving VPAC2, NK2, NMDA receptors and glial cytokine production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Enzyme Inhibitors / pharmacology
  • Inflammation Mediators / pharmacology
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Male
  • Mitogen-Activated Protein Kinase 1 / drug effects
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Neuralgia / metabolism
  • Neuralgia / physiopathology
  • Neuroglia / drug effects
  • Neuroglia / metabolism*
  • Neuroprotective Agents / pharmacology
  • Peripheral Nerve Injuries
  • Peripheral Nerves / metabolism
  • Peripheral Nerves / physiopathology
  • Peripheral Nervous System Diseases / metabolism*
  • Peripheral Nervous System Diseases / physiopathology
  • Phosphorylation / drug effects
  • Physical Stimulation
  • Posterior Horn Cells / drug effects
  • Posterior Horn Cells / metabolism*
  • Rats
  • Rats, Wistar
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Receptors, Neurokinin-2 / drug effects
  • Receptors, Neurokinin-2 / metabolism*
  • Receptors, Vasoactive Intestinal Peptide, Type II / drug effects
  • Receptors, Vasoactive Intestinal Peptide, Type II / metabolism*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / metabolism
  • Xanthines / pharmacology
  • p38 Mitogen-Activated Protein Kinases / drug effects
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Enzyme Inhibitors
  • Inflammation Mediators
  • Neuroprotective Agents
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurokinin-2
  • Receptors, Vasoactive Intestinal Peptide, Type II
  • Tumor Necrosis Factor-alpha
  • Xanthines
  • propentofylline
  • Mitogen-Activated Protein Kinase 1
  • p38 Mitogen-Activated Protein Kinases